JTI’s Nordic Spirit Signs Co-op Live Partnership Ahead of New UK Nicotine Sponsorship Restrictions

Sep.07
JTI’s Nordic Spirit Signs Co-op Live Partnership Ahead of New UK Nicotine Sponsorship Restrictions
JTI nicotine pouch brand Nordic Spirit has entered a long-term partnership with Manchester’s Co-op Live, becoming the venue’s Official Nicotine Pouch Partner. The 23,500-capacity venue is the UK’s largest indoor live entertainment arena. Nordic Spirit will run in-venue activations for existing adult nicotine consumers and sell products at selected arena bars. The agreement was entered into before the relevant UK sponsorship restrictions were introduced, while the government intends to implement a comprehensive ban on advertising and sponsorship of vaping and nicotine products from June 1, 2027.

Key Points

  • Nordic Spirit has become Co-op Live’s Official Nicotine Pouch Partner under a long-term agreement.
  • The brand will run in-venue activations for existing adult nicotine consumers and sell products at selected bars.
  • Co-op Live in Manchester has a maximum capacity of 23,500 and is the UK’s largest indoor live entertainment arena.
  • The UK intends to introduce comprehensive advertising and sponsorship restrictions for vaping and nicotine products from June 1, 2027; the partnership was entered into before the relevant sponsorship restrictions.

2Firsts

September 7, 2026

According to UK retail trade publication Grocery Trader on September 3, 2026, Japan Tobacco International’s nicotine pouch brand Nordic Spirit has signed a long-term partnership with Manchester’s Co-op Live, becoming the venue’s Official Nicotine Pouch Partner.

Under the agreement, Nordic Spirit will deliver in-venue activations aimed at existing adult nicotine consumers, while its products will also be available for purchase at selected bars inside the arena.

The partnership comes as the UK prepares for a major change in the rules governing the marketing and sponsorship of nicotine products.

Nordic Spirit Moves Into Major Live Entertainment

Opened in 2024 on Manchester’s Etihad Campus, Co-op Live can accommodate up to 23,500 people and describes itself as the UK’s largest indoor live entertainment arena.

The venue hosts major music acts, sporting events and comedy shows.

For Nordic Spirit, the agreement expands the brand beyond conventional grocery, convenience and independent retail channels into a large-scale live entertainment setting.

Jason De Lencastre, Consumer & Brand Activation Lead Manager at JTI UK, said the partnership was intended to help adult nicotine users remain inside the venue throughout an event rather than leaving to smoke or vape.

Co-op Live Senior Vice President and General Manager Guy Dunstan said the venue plans to work with JTI on a range of in-venue activations.

Smoke- and Vapour-Free Format Supports Venue Strategy

Nordic Spirit is a tobacco-free nicotine pouch product that does not generate smoke or vapour during use.

That format allows nicotine pouches to be used in some indoor environments where smoking or vaping may be restricted.

In the UK, Nordic Spirit is sold across strength levels from Regular to Max and in flavours including Sweet Mint, Raspberry, Dark Fizz and Blueberry.

Commercially, the Co-op Live agreement therefore goes beyond simple product distribution. It links the characteristics of nicotine pouches with a specific consumption occasion: extended attendance at live entertainment events.

For nicotine pouch brands, arenas provide long-duration consumer occasions and concentrated adult audiences, while the smoke- and vapour-free format creates a different set of use-case opportunities from cigarettes and vaping products.

Timing Matters as UK Sponsorship Rules Change

Grocery Trader specifically noted that the long-term agreement was entered into before the introduction of the relevant sponsorship restrictions.

The UK’s Tobacco and Vapes Act 2026 extends advertising and sponsorship controls to vaping and other nicotine products.

The Department of Health and Social Care has said the government intends to implement a comprehensive ban on advertising and sponsorship of vaping and nicotine products from June 1, 2027.

At present, other nicotine products such as nicotine pouches are not subject to a comprehensive advertising and sponsorship ban comparable with tobacco.

The new framework will make certain business sponsorship arrangements that promote vaping or nicotine products an offence once the relevant provisions are in force.

The timing of the Nordic Spirit agreement, however, is legally significant.

Section 131 of the Tobacco and Vapes Act links the new sponsorship offence for vaping and nicotine products to when an agreement is entered into and when the relevant provisions take effect. Grocery Trader states that the Nordic Spirit-Co-op Live agreement predates the relevant restrictions.

It would therefore be inaccurate to state simply that the partnership will automatically become prohibited in 2027. Its treatment will depend on commencement rules, secondary legislation and further government guidance.

UK Nicotine Pouch Marketing Environment Set to Change

The UK government has acknowledged that nicotine pouches currently face no comprehensive advertising and sponsorship restrictions.

That environment is set to change under the new legislation.

The government intends to expand the regulatory framework to cover sponsorship, online advertising and other forms of promotion for nicotine products.

The transition from 2026 into 2027 could therefore become an important dividing line for nicotine pouch marketing strategies in the UK.

Nordic Spirit’s Co-op Live agreement illustrates both JTI’s effort to expand the brand’s physical consumer touchpoints and the importance of timing as the UK moves toward tighter marketing controls.

Beyond the Retail Shelf

Nordic Spirit is already distributed through major UK supermarkets, independent retailers and online channels.

Its entry into Co-op Live represents a further attempt to build consumer touchpoints beyond the retail shelf and into specific usage occasions.

More broadly, nicotine pouch competition is increasingly extending beyond strength, flavour and retail distribution into lifestyle and entertainment settings.

As the UK moves toward comprehensive restrictions on nicotine-product advertising and sponsorship, however, the ways brands can use venue partnerships, activations and consumer communications will become increasingly shaped by regulation.

The significance of the Co-op Live deal therefore lies not only in Nordic Spirit entering the UK’s largest indoor arena, but also in the fact that the agreement arrives at a transition point for nicotine pouch marketing rules.

Follow 2Firsts for timely updates on global tobacco and nicotine industry developments, corporate strategy and market trends.

Cover Image: Grocery Trader


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
Huabao’s H1 2026 results show the company advancing across three connected fronts: international expansion, entry into next-generation tobacco supply chains and diversification beyond its traditional tobacco-related base. Overseas revenue rose 216.08% to CNY 96.02 million, while non-flavor businesses reached 42.2% of total revenue. Huabao also said it had entered the supply chains of leading global tobacco customers, as its nutrition, food ingredient, fragrance and personal-care businesses gained ground in Europe, Southeast Asia, Australia and New Zealand. However, adjusted net profit increased only 2.78%, and next-generation tobacco revenue was not separately disclosed, showing that the transformation is reshaping revenue and customer exposure but has yet to translate fully into underlying earnings.
Aug.28
Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands has agreed to acquire 100% of Swedish modern oral nicotine company Yoik Group AB for an initial SEK515 million, equivalent to about US$53.9 million, plus a deferred payment linked to performance over the next two years. Yoik owns nicotine pouch brand Helwit, which held about 3.4% of Sweden’s modern oral nicotine market over the past 12 months. Imperial says the acquisition will more than double its existing share of the Swedish market. Helwit is also sold elsewhere in the Nordics, through European online channels and in selected UK retail outlets.
Sep.08
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
Philip Morris International's IQOS has extended its partnership with electronic-music event brand ZAMNA to Spain, setting up a House of IQOS at ZAMNA Madrid. Vogue España and Time Out Madrid subsequently published branded content clearly labeled as collaborations with IQOS. PMI has also expanded its company-owned IQOS boutique network in Spain to seven cities this year. The company says IQOS's adjusted heated-tobacco market share in Europe reached 12.6% in the first quarter of 2026, with Spain among its stronger-performing European markets.
Sep.20
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives